A Long-term Safety Extension Study of Tocilizumab in Brazilian Participants With Rheumatoid Arthritis (RA) Who Completed the Studies ML21530 and MA21488
Clinical trial NCT01715831 · COMPLETED
Trial details
- NCT number
- NCT01715831
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2013-01-15
- Primary completion
- 2016-06-06
- Enrollment
- 26
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.